Unveiling the Journey of MAOIs in Clinical Practice

Join us in this mini-mindset episode as we dive deeply into the history, development, and modern-day relevance of Monoamine Oxidase Inhibitors (MAOIs) in clinical practice. From their origins in the 1950s as accidental discoveries from hydrazine compounds to their niche use today, we explore the myths, misconceptions, and clinical implications of these 'relics' of psychiatry. Learn about the various MAOIs, their discovery stories, pharmacological effects, and the impact they had—and continue to have—on the field of psychotropic medications. Whether you're a healthcare professional or a curious learner, this episode sheds light on the importance of understanding the history and evolution of psychiatric medications.